1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Global Drug Discovery and Development Analysis & Statistics, August 2017

Global Drug Discovery and Development Analysis & Statistics, August 2017

1-30 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

Anti-Knock Preparation Markets in Europe to 2021 - Market Size, Development, and Forecasts

  • $ 12090
  • Industry report
  • July 2017
  • by Global Research & Data Services

The report package Anti-Knock Preparation Markets in Europe to 2021 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook ...

  • Industries : Drug Discovery and Development
  • Countries : Europe

Anti-Knock Preparation Markets in Asia to 2021 - Market Size, Development, and Forecasts

  • $ 9031
  • Industry report
  • July 2017
  • by Global Research & Data Services

The report package Anti-Knock Preparation Markets in Asia to 2021 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook fo ...

  • Industries : Drug Discovery and Development
  • Countries : Asia

Anti-Knock Preparation Markets in Eastern Europe to 2021 - Market Size, Development, and Forecasts

  • $ 8765
  • Industry report
  • July 2017
  • by Global Research & Data Services

The report package Anti-Knock Preparation Markets in Eastern Europe to 2021 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future ...

  • Industries : Drug Discovery and Development
  • Countries : Europe

Anti-Knock Preparation Markets in Western Europe to 2021 - Market Size, Development, and Forecasts

  • $ 6504
  • Industry report
  • July 2017
  • by Global Research & Data Services

The report package Anti-Knock Preparation Markets in Western Europe to 2021 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future ...

  • Industries : Drug Discovery and Development
  • Countries : Europe

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • $ 4995
  • Industry report
  • July 2017
  • by GBI Research

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Colorectal cancer (CRC) originates in eithe ...

  • Industries : Therapy, Cancer, Pharmaceutical, Pathology
  • Countries : World

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

  • $ 4995
  • Industry report
  • July 2017
  • by GBI Research

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis Summary Dermatology is a highly diverse therapy area that ...

  • Industries : Healthcare, Health Services
  • Countries : World

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

  • $ 4995
  • Industry report
  • June 2017
  • by GBI Research

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth Summary Immune-mediated inflammatory diseases ...

  • Industries : Healthcare, Health Services
  • Countries : World

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

  • $ 4995
  • Industry report
  • June 2017
  • by GBI Research

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse Summary Pain can be classified into three main categories. ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World

Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market

  • $ 4995
  • Industry report
  • June 2017
  • by GBI Research

Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market Summary Asthma is a common chronic inflammatory disease of the ...

  • Industries : Therapy, Chronic Disease, Pharmaceutical, Pathology
  • Countries : World

Global Clinical Trials Market

  • $ 4500
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

The clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) of 7.5%, ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World

Global Clinical Trials Consumables Market 2017-2021

  • $ 3500
  • Industry report
  • June 2017
  • by Infiniti Research Limited

About Clinical Trials Consumables Clinical trials are research studies that are undertaken to test a drug or a medical device before it is launched in the market. The data generated from these studies ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) – Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • August 2017
  • by Global Markets Direct

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) – Pipeline Review, H2 2017 Summary Prostaglandin ...

  • Industries : Pathology, Chronic Disease, Therapy, Pharmaceutical
  • Countries : World, United States

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) – Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • August 2017
  • by Global Markets Direct

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) – Pipeline Review, H2 2017 Summary According to the recently published report ’Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : World, United States

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2017 Summary According to the recently published ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2017 Summary Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) pipeline Target constitutes close to 6 molecules. ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : World

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2017 Summary Rho ...

  • Industries : Health Services, Pharmaceutical, Cancer, Therapy, Drug Discovery and Development
  • Countries : United Kingdom, World

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2017 Summary According to the recently published report ’Granulocyte Macrophage ...

  • Industries : Therapy, Biological Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States, World

Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Pipeline Review, H1 2017 Summary Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) pipeline Target constitutes close to 7 molecules. ...

  • Industries : Mental Health, Pathology
  • Countries : World

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - Pipeline Review, H1 2017 Summary 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) pipeline Target ...

  • Industries : Pharmaceutical, Therapy, Mental Health, Pathology
  • Countries : United States, World

Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Pipeline Review, H1 2017 Summary Prostate Specific Antigen (Gamma Seminoprotein ...

  • Industries : Therapy, Cancer, Oncology, Pathology
  • Countries : United States, World, Mexico

Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, H1 2017 Summary According to the recently published report 'Caspase 6 - Pipeline Review, H1 2017'; Caspase 6 (Apoptotic ...

  • Industries : Pathology
  • Countries : World, United States

Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline ...

  • Industries : Pathology, Therapy
  • Countries : Europe, Italy, World

Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H1 2017 Summary Toll Like Receptor 8 (CD288 or TLR8) - Toll-like receptor 8 is a protein encoded by the TLR8 gene. It control host immune response ...

  • Industries : Pathology, Therapy, Pharmaceutical, Cancer
  • Countries : United States, World

Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Pipeline Review, H1 2017 Summary Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease ...

  • Industries : Pathology
  • Countries : United States, World

Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H1 2017 Summary Acyl CoA Desaturase (Fatty Acid Desaturase or Delta ...

  • Industries : Pathology, Pharmaceutical, Therapy, Healthcare
  • Countries : United States, World

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, ...

  • Industries : Therapy, Pharmaceutical, Chronic Disease, Pathology, Drug Discovery and Development
  • Countries : Australia, World, United States

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017 Summary T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - CD28 is a proteins expressed on T cells. It co-stimulates ...

  • Industries : Therapy, Biological Therapy, Drug Discovery and Development, Pathology
  • Countries : World, United States

Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H1 2017 Summary According to the recently published report 'Caspase ...

  • Industries : Pathology, Therapy, Cancer
  • Countries : United States, World

Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Therapy
  • Countries : World

Crow Feet Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Crow Feet Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Crow Feet Global Clinical Trials Review, H2, 2017" provides an overview of Crow Feet clinical trials scenario. ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.